SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001760854-23-000015
Filing Date
2023-09-26
Accepted
2023-09-26 16:33:30
Documents
120
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 6-K nbx-20230630.htm   iXBRL 6-K 2168054
2 EX-99.2 exhibit992-202306xsummaryo.htm EX-99.2 30479
3 EX-99.3 exhibit993-202306xsuppleme.htm EX-99.3 6124
  Complete submission text file 0001760854-23-000015.txt   14739593

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nbx-20230630.xsd EX-101.SCH 129371
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nbx-20230630_cal.xml EX-101.CAL 90398
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nbx-20230630_def.xml EX-101.DEF 547323
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nbx-20230630_lab.xml EX-101.LAB 970753
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nbx-20230630_pre.xml EX-101.PRE 766063
114 EXTRACTED XBRL INSTANCE DOCUMENT nbx-20230630_htm.xml XML 2931325
Mailing Address 60 RUE DE WATTIGNIES PARIS I0 75012
Business Address 60 RUE DE WATTIGNIES PARIS I0 75012 33140260470
Nanobiotix S.A. (Filer) CIK: 0001760854 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39777 | Film No.: 231280842
SIC: 2834 Pharmaceutical Preparations